Ongoing treatment(s)-Immunotherapy Posts on Medivizor
Navigation Menu

Ongoing treatment(s)-Immunotherapy Posts on Medivizor

Association of side effects and response to treatment in patients with melanoma treated with nivolumab

Posted by on Dec 27, 2018 in Melanoma | 0 comments

In a nutshell This study wanted to find out if patients with melanoma who had immune system side effects after treatment with nivolumab (Opdivo) had better outcomes than patients without side effects. The study found that the patients who had side effects from using nivolumab ended up with better responses to treatment and...

Read More

The effect of FDG-PET imaging on patients with melanoma treated with immunotherapy.

Posted by on Sep 28, 2018 in Melanoma | 0 comments

In a nutshell The study looked at the use of FDG-PET imaging to assess long-term outcomes of treatment in patients with melanoma. Researchers found that FDG-PET imaging may be useful in predicting long-term outcomes of treatment in these patients. Some background Treatment for melanoma has vastly improved in recent years. Immunotherapies have improved...

Read More

Comparison of lapatinib and trastuzumab in patients with HER-2 receptor positive breast cancer

Posted by on Jul 2, 2018 in Breast cancer | 0 comments

In a nutshell This study aimed to compare lapatinib (Tykerb) and trastuzumab (Herceptin) in patients with HER-2 receptor positive breast cancer. This study found that in patients with hormone receptor-positive tumors, use of lapatinib for 6 months, followed by trastuzumab for 12 months significantly improved survival...

Read More

Does age effect immunotherapy treatment in melanoma?

Posted by on Oct 16, 2017 in Melanoma | 0 comments

In a nutshell The study examined if age played a role in the effect of immunotherapy treatment on patients with melanoma. The study concluded that immunotherapy is similarly effective in patients of all ages. Some background Immunotherapy is a type of treatment which targets the immune system to help it to fight cancer. A specific type of...

Read More

A Message of Hope for New Combination Therapies in Melanoma

Posted by on Sep 28, 2017 in Melanoma | 0 comments

Video information: In this replay, medical oncologist/melanoma specialist Dr. Michael Postow joins Patient Power host Andrew Schorr online from Memorial Sloan Kettering Cancer Center to discuss combination therapies for patients with advanced melanoma. In the online chat, Andrew and Dr. Postow discuss how patients can get life-extending treatments...

Read More

Skin complications associated melanoma treatment with nivolumab or pembrolizumab

Posted by on Oct 29, 2016 in Melanoma | 0 comments

In a nutshell This study investigated the negative effects on the skin associated with the use of nivolumab (Opdivo) to treat melanoma. Researchers suggested that skin complications are the most frequent side effects but they are in most cases manageable. Some background The use of PD-1 antibodies, such as nivolumab (Opdivo) or pembrolizumab...

Read More